High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
A new study shows that a shift from quiescent to activated liver cells sets the stage for liver cancer and suggests ways to reduce the risk of developing the cancer in people with liver disease.
Studies show it affects about 1 percent of the population, said Dr. Paul S. Appelbaum, a professor of psychiatry at Columbia University, though “many of those people may have quite mild cases.”
Editor's Note: Jan Claassen, a co-author of this article, is an associate professor in the Department of Neurology at the Vagelos College of Physicians and Surgeons.
Editor's Note: Wafaa El-Sadr, a co-author of this opinion piece, is founder and director of ICAP at the Mailman School of Public Health and executive vice president for Columbia Global.
Ghosh was elected for his elected for his pioneering studies of the immune system and establishing strategies for the treatment of inflammatory diseases and cancer.
Project Engage, an initiative of the Department of Psychiatry, is training community workers to deliver brief, evidence-based interventions for people with mental illnesses and addictions.
